Background/Objectives: Postprandial lipaemia is an established risk factor for atherosclerosis. To investigate the acute effect of four milk-derived dietary proteins (alpha-lactalbumin, whey isolate, caseinoglycomacropeptide and whey hydrolysate) on postprandial lipaemia, we have conducted a randomized, acute, single-blinded clinical intervention study with crossover design. Subjects/Methods: A total of 11 obese non-diabetic subjects (age: 44-74, BMI: 30-41.4 kg m -2 ) were included. On 4 different days the subjects ingested a high-fat meal with the following energy distribution: 66% energy from fat (100 g of butter), 15% of energy from carbohydrate (90 g of white wheat bread) and 19% of energy from protein (45 g of pure protein). Our primary variable was plasma triglyceride measured in the 8-h postprandial period. Secondarily, retinyl palmitate, non-esterified free fatty acids, glucose, insulin, glucagon, GLP-1 and GIP, active and total grehlin and cholecystokinin were measured. Results: We observed no statistically significant (P ¼ 0.8) differences between meals on our primary variable that is, triglycerides. Whey hydrolysate was associated with a significantly (P ¼ 0.02) smaller postprandial suppression of non-esterified free fatty acids compared with the other dietary proteins. Conclusion: We did not observe significant differences in postprandial lipaemia to the four milk-derived dietary proteins. Whey hydrolysate caused less postprandial suppression of free fatty acids.
Introduction
Obesity is at epidemic proportions worldwide. Obesity is a significant risk factor for and contributor to increased morbidity and mortality, most importantly from cardiovascular disease and diabetes (Yusuf et al., 2005) . Thus, obesity is strongly associated with an increased risk of all-cause mortality as well as cardiovascular mortality (Teucher et al., 2010) . The increased risk of cardiovascular disease linked to obesity is caused by a combination of silent risk factors such as hypertension, insulin resistance, inflammation and dyslipidaemia (Sehested et al., 2010) .
In relation to dyslipidaemia, postprandial lipaemia (PPL) is a key contributor to cardiovascular disease risk and progression (Bansal et al., 2007; Nordestgaard et al., 2007) . Specifically, delayed clearance of chylomicrons (CM) and their remnants increase the delivery of triglyceride and cholesteryl ester to the vessel wall and can accelerate the progression of atherosclerosis, which may be particularly pertinent to individuals with obesity and insulin resistance (Guerci et al., 2000) . An exaggerated PPL response in both increment and duration is observed in both type 2 diabetes (T2DM) (Madhu et al., 2008) and obesity (Couillard et al., 1998; Guerci et al., 2000; van Wijk et al., 2003) .
The extent of PPL is primarily correlated to the diet in general and fat content of meals in particular (Lairon, 2008) . Interestingly, it has been demonstrated that the addition of refined carbohydrates to a fat-rich meal increases PPL in T2DM (Brader et al., 2010) . However, this observation could not be demonstrated in healthy subjects (Westphal et al., 2004; Lairon et al., 2007) .
In recent years, increased scientific interest has been paid to the acute effects of dietary protein on PPL. Thus, the unfavorable effect of carbohydrate on PPL seen in T2DM can be reduced by adding casein to the meal (Westphal et al., 2004; Brader et al., 2010) . However, casein added to a fat-rich meal without carbohydrate did not affect PPL compared with a fat-rich meal per se in T2DM (Brader et al., 2010) . In addition, Nilsson et al. (2004) showed that milk proteins in general and whey protein in particular have the most insulinotropic abilities among a wide range of dietary proteins. Regarding the importance of insulin on postprandial glucose and fat metabolism, it occurs that dietary proteins have differential impact. Thus, Mortensen et al. (2009) recently demonstrated that whey protein reduce PPL in T2DM compared with casein, gluten and cod protein, and Akhavan et al. (2010) and Frid et al. (2005) found lower postprandial glycaemia in young, healthy adults and T2DM following premeal consumption of whey protein. The impact of dietary protein on PPL in obese non-diabetic subjects is unknown.
We hypothesize, that whey protein has a beneficial effect on PPL in obese non-diabetic subjects. The proposed beneficial effect is thought to be caused by a subfraction of whey. In this study, we have compared the effects on PPL of a structurally modified derivate of whey isolate (WI) and two subfractions of whole whey. The structurally modified derivate is whey hydrolysate (WH), that primarily consists of di-and tripeptides from extensively hydrolysed WI. The two subfractions are alpha-lactalbumin (ALPH) and caseinoglycomacropeptide (CGMP), both major fractions of whey but here given as ALPH-enhanced whey protein and CGMP-enhanced whey protein. As comparator we have used WI.
Subjects and methods

Subjects
A total of 11 obese Caucasian subjects (six postmenopausal women and five men) were recruited by advertising in local newspapers. All subjects had a BMI above 30 and were non-diabetics as determined by fasting glucose levels o7.0 mmol/l. Subjects with impaired fasting glucose were subjected to an oral glucose tolerance test before enrolment, and were excluded if diabetic (one subject). No participant took lipid-lowering drugs and all participants were nonsmokers. Subject characteristics are shown in Table 1 . No change in concomitant medication was allowed during the trial. All subjects gave written informed consent, and the study was approved by the Committees on Biomedical Research Ethics for the Central Region of Denmark. This study is registered on Clinicaltrials.gov ID: NCT00809874.
Study design
In accordance with a randomized, single-blinded, acute study with crossover design, all subjects ingested four different meals at 2 weeks interval between meals. Each subject was randomized to one of four test meal sequences according to a Latin square. Each subject was given a standard diet that is to be consumed on the day preceding each study day. The diet had the following energy distribution: 56% energy from carbohydrate, 24% energy from fat and 20% energy from protein. The energy content was 7000 and 9000 kJ for female and male participants, respectively. In the morning after a 12-h fasting period the subjects were instructed to minimize their physical activity. Upon arrival at the research facility baseline samples were drawn after 15 min of rest. The test meal was ingested within 20 min and during the 8-h postprandial period blood samples were drawn regularly. Insulin, glucagon like peptide 1 (GLP-1), glucose-dependent insulinotropic peptide (GIP) and glucose were measured at 0, 15, 30, 45, 60, 120, 240, 360 and 480 min. Glucagon, active grehlin, total grehlin and cholecystokinin (CCK) were measured at 0, 30, 60, 120, 240, 360 5.9 ± 0.6 (4.8-6.9) 5.9 ± 0.3 (4.8-6.9) 6.0 ± 0.2 (5.6-6.8) HOMA2 (IR)
1.0 ± 0.4 (0.5-1.7) 0.8 ± 0.1 (0.5-1.2) 1.3 ± 0.2 (0.9-1.7) Fasting P-triglyceride (mmol/l) 1.4 ± 0.5 (0.5-2.3) 1.3 ± 0.2 (0.5-1.9) 1.4 ± 0. (Blomhoff et al., 1991) and is used as a marker of lipoproteins of intestinal origin, that is, chylomicrons and chylomicron remnants (Chen and Reaven, 1991) in the postprandial period. Macronutrient distribution and energy content of the four meals is shown in Table 2 . Lactose content of each meal did not differ. The total volume of each meal did not differ.
Ultracentrifugation
To isolate chylomicrons from lower density lipoproteins, that is, VLDL, IDL, LDL and chylomicron remnants, we performed a single step of ultracentrifugation on our plasma samples. Plasma samples were defrosted at 4C. Plasma (4 ml) was overlayered with 2 ml of a saline solution with a density of 1006 g/ml in a quick seal tube (number 344 619; Beckman Instruments, Palo Alto, CA, USA) and then centrifuged for 30 min at 26 000 Â g at 25 1C. The chylomicron-rich supernatant (Svedberg flotation (Sf) 41000) was aspirated and brought to a final volume of 4 ml with saline. The chylomicron-poor infranatant contained the more dense lipoproteins (Sf o1000). Total GIP was measured as described previously (Krarup et al., 1983) . The plasma concentrations of total GLP-1 were measured using antiserum code number 89 390 (Krarup et al., 1983) . Thus, it mainly reacts with GLP-1 of intestinal origin. For both assays, sensitivity was o1 pmol/l and the interassay CV was o6% at 20 pmol/l. Glucagon of mainly pancreatic origin was measured by radioimmunoassay using antibody number 4305 in ethanol-extracted plasma as described previously (Holst, 1982; Orskov et al., 1991) . RP was extracted and measured by isocratic absorption high-performance liquid chromatography as described previously (Biesalski, 1990) .
Blood analyses
CCK was measured using the EURIA-CCK kit (EURO-DIAGNOSTICA AB, Malmö, Sweden) (CV 13.7%). Active grehlin was estimated with the Grehlin RIA kit (GHRA-88HK, Linco Research, Billerica, MA, USA) (CV 9.6%). Total grehlin was measured with the Grehlin RIA kit (GHRT-89HK, Millipore, Billerica, MA, USA) (CV 14.7%).
Statistical analysis and calculations
To achieve a statistical power of 80%, the number of subjects needed was 10 based on power calculations to detect a difference of 30% between meals on our primary variable, triglyceride. Comparisons of the iAUC's were based on a mixed-effects model (Rabe-Hesketh, 2008) (STATA/IC 10.1), using treatment group as fixed variable and participant ID as random variable. All statistical comparisons were adjusted Response data were given as net incremental area under the curve after 480 min (net iAUC-480 min) using trapezoidal rule. However, as previously shown, plasma insulin reaches baseline at 240 min after a fat-rich mixed meal in nondiabetic subjects (Thomsen et al., 1999) . Therefore, response data on insulin were given at 240 min. To describe initial responses of insulin, glucagon, GLP-1 and GIP data were also presented as net iAUC after 30 min (net iAUC-30 min) in the results section. Whenever data were not normally distributed, a log transformation was performed and the statistical analyses were carried out on the normal distributed log data and results given as medians with interquartile ranges. Otherwise data were given as means±s.d. unless otherwise stated.
Results
All 11 obese non-diabetic participants completed the four test meals according to the protocol. We found no significant differences in body weight or fasting concentrations of the measured variables between test days (Table 3) .
Lipaemic responses
No significant differences in plasma triglycerides, supernatant triglycerides or infranatant triglycerides were observed between meals (Table 4) . Concordantly, we observed no significant differences in RP supernatant or RP infranatant (Table 4) .
NEFA and glucose
All meals suppressed postprandial NEFA concentrations. However, the overall suppression of NEFA after WH-meal was significantly (P ¼ 0.0219) smaller compared with the three other meals (Table 4) . No statistically significant differences were observed in postprandial glucose net iAUC-480 min (Table 4 ) or in glucose net iAUC-30 min (data not shown).
Hormone responses
There were no overall significant differences in postprandial insulin net iAUC-480 min between meals (Table 4) . However, WH-meal induced a significantly (P ¼ 0.0112) larger net iAUC-30 min of insulin compared with the three other meals (Table 4 ). The insulin net iAUC-30 min of WH-meal was 6928 pmol/l per 30 min;±5476. The insulin net iAUC-30 min of ALPH-, WI-, and CGMP-meal accounted for 46%, 59% and 62% of that to WH-meal, respectively. No significant differences were observed in postprandial responses of glucagon, incretin hormones, CCK or grehlin (Table 4) .
Discussion
The present study evaluated the acute effects of milk-derived dietary proteins on postprandial lipaemia in obese nondiabetic subjects. We compared four different isocaloric meals with the same nutrient distribution but with four different protein sources, that is, alpha-lactalbumin, whey isolate, caseinoglycomacropeptide and whey hydrolysateall milk derived. The most important findings were a smaller postprandial suppression of NEFA after WH-meal compared with the other meals and a larger insulin increment during the initial 30 min after WH-meal compared with the other meals. We did not observe significant differences between meals in our primary outcome that is, postprandial lipaemia.
As expected, we found a suppression of NEFA for all four meals. The suppression observed after WH-meal was only about one third of what we saw after the other meals. In the postprandial state the adipose tissue shifts from triglyceride (Ruge et al., 2009) . In the present study, however, we found no differences in substrate availability, that is, triglycerides, to explain the differences in postprandial NEFA concentrations. We did demonstrate, although, that the insulin response was initially higher after WH-meal compared with the other meals. However, higher insulin concentrations would physiologically lead to larger postprandial suppression of NEFA unless the meal had caused a state of acute insulin resistance. NEFA derived from serum triglycerides are known to increase hepatic glucose production and induce hepatic insulin resistance (Lam et al., 2003) . However, it occurs unlikely that WH-meal would induce acute postprandial insulin resistance within the initial 30 min. The insulinotropic properties of whey protein are described earlier. Thus, whey protein is rich in essential amino acids and branched chained amino acids that possess strong insulinotropic properties (Floyd et al., 1970) . Furthermore, whey hydrolysate has been found to elicit higher insulin responses compared with whole milk (Calbet and Maclean, 2002) . Interestingly, although, comparison of oral administration of native whey protein and hydrolysed whey protein or hydrolysed casein revealed no differences in gastric emptying or appearance of amino acids in peripheral blood (Calbet and Holst, 2004) . The different insulinotropic properties may on the other hand be attributed to differential stimulation of intestinal GIP secretion as demonstrated by Calbet and Holst (2004) . In the present study, we observed a tendency for WH-meal to elicit larger GIP responses compared with the other meals. Thus, our findings regarding incretin hormones, glucagon and insulin corroborate well with the findings of Calbet and Holst (2004) and Claessens et al. (2008) . Furthermore, Power et al. (2009) demonstrated augmented insulinotropic effects of WH compared with WI following ingestion of a protein solution, but did not see any differences in gastric emptying.
We did not observe acute differential effects of the four test meals on postprandial lipaemia. However, in both supernatant and infranatant triglyceride net iAUC-480 min tended to be lower following CGMP-meal compared with the other meals. This corroborates with the tendency of lower concentrations of incretin hormones after CGMP-meal as this may reflect a slower rate of gastric emptying. However, there are limitations that need to be acknowledged and addressed regarding the present study. Because of the relatively small sample size, we may not have been able to detect a potential treatment effect in the triglyceride supernatant and infranatant. Furthermore, it is debatable whether an ultracentrifugation time of 30 min is sufficient to secure all chylomicron triglyceride as it has been argued that a few hours of centrifugation is needed. Moreover, we did not carry out measurements of gastric emptying, fecal lipid content or lipoprotein lipase concentrations, which could have helped elucidating postprandial kinetics of the four protein meals. Also, it appears puzzling that the recovery percentage of triglyceride in the two ultracentrifuged plasma fractions was smaller after CGMP-meal compared with the other meals. Plasma samples were stored and handled in order of the randomized test sequence, which would otherwise prevent meal categorical differences in blood analyses and ultracentrifugation techniques. It is to be expected that the sum of the two ultracentrifuged fractions do not add up to total triglyceride. However, we cannot exclude that the inter-meal differences in recovery percentage can explain some of the variation observed. The variation in HOMA between men and women in the present study could potentially cause gender differences to outcomes. However, post hoc analyses did not demonstrate any gender differences to outcomes (data not shown).
We labeled the chylomicrons with vitamin-A to get an approximation of the chylomicron concentration at a given time. It has, although, been demonstrated that RP is not exclusively associated to chylomicrons but is interchangeable to other lipoproteins in the late postprandial phase. Furthermore, RP concentrations in each lipoprotein are correlated to the size of the particle with more RP in larger particles (Karpe et al., 1995) . In both supernatant and infranatant RP tended to be lower after CGMP meal. During the postprandial period chylomicrons undergo lipolysis leaving smaller and theoretically atherogenic (Karpe et al., 2001 ) chylomicron remnant particles. The long-term clinical impact of fewer chylomicrons and less triglyceride in the blood during the postprandial period may consequently be a reduction in cardiovascular risk.
We found no differences between meals in grehlin or CCK. Several studies have shown diminished or absent postprandial suppression of grehlin in obese subjects (Neary and Batterham, 2009 ) compared with lean subjects following meals with energy content ranging from 250 to 3000 kcal. Even so, the physiological and potentially antiobesity effect of grehlin and CCK in obese subjects is still debated (Field et al., 2010) .
In the present study, we have demonstrated differential acute effects of whey-derived dietary proteins on PPL. The detrimental effect of excess NEFA, the so called lipotoxicity, contributes to insulin resistance (Bergman and Ader, 2000) and therefore, the weaker suppression of NEFA by WH-meal may relatively enhance long-term insulin resistance in obese non-diabetic individuals compared with the other meals. The high-fat test meals were based on the recommended method (Kolovou et al., 2011) to study postprandial lipaemia but do obviously not reflect a normal diet. Consequently, there is a need for further insight into mechanisms and pathways to understand the observed disparity, as well as long-term studies on ordinary diets to assess the clinical implications of protein supplementation in obese nondiabetic subjects.
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